Key points are not available for this paper at this time.
Idiopathic pulmonary fibrosis (IPF) is a progressive, debilitating lung disease with poor prognosis. Although two antifibrotics have been approved in the past decade there are no curative therapies.
Macisaac et al. (Tue,) studied this question.